Sartorius Stedim Biotech S.A.
$19.32+2.38%(+$0.45)
TickerSpark Score
49/100
50
Valuation
70
Profitability
25
Growth
72
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRTOY research report →
52-Week Range22% of range
Low $17.25
Current $19.32
High $26.54
Companywww.sartorius.com
Sartorius Stedim Biotech S. A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide.
- CEO
- Rene Faber
- IPO
- 2022
- Employees
- 9,961
- HQ
- Aubagne, FR
Price Chart
-14.63% · this period
Valuation
- Market Cap
- $187.94B
- P/E
- 59.44
- P/S
- 5.34
- P/B
- 3.88
- EV/EBITDA
- 21.40
- Div Yield
- 0.42%
Profitability
- Gross Margin
- 44.71%
- Op Margin
- 18.47%
- Net Margin
- 8.98%
- ROE
- 6.60%
- ROIC
- 5.47%
Growth & Income
- Revenue
- $2.85B · 2.53%
- Net Income
- $255.12M · 45.70%
- EPS
- $0.03 · -85.64%
- Op Income
- $527.33M
- FCF YoY
- -70.62%
Performance & Tape
- 52W High
- $26.54
- 52W Low
- $17.25
- 50D MA
- $19.59
- 200D MA
- $21.89
- Beta
- 1.09
- Avg Volume
- 98.42K
Get TickerSpark's AI analysis on SRTOY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SRTOY Coverage
We haven't published any research on SRTOY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SRTOY Report →